Skip to main content
Top
Published in: Immunity & Ageing 1/2022

Open Access 01-12-2022 | Correction

Correction: Salutary effects of moderate but not high intensity aerobic exercise training on the frequency of peripheral T-cells associated with immunosenescence in older women at high risk of breast cancer: a randomized controlled trial

Authors: Grace M. Niemiro, Adriana M. Coletta, Nadia H. Agha, Preteesh Leo Mylabathula, Forrest L. Baker, Abenaa M. Brewster, Therese B. Bevers, Enrique Fuentes-Mattei, Karen Basen-Engquist, Emmanuel Katsanis, Susan C. Gilchrist, Richard J. Simpson

Published in: Immunity & Ageing | Issue 1/2022

Login to get access

Excerpt

Correction to: Immun Ageing 19, 17 (2022).
Literature
Metadata
Title
Correction: Salutary effects of moderate but not high intensity aerobic exercise training on the frequency of peripheral T-cells associated with immunosenescence in older women at high risk of breast cancer: a randomized controlled trial
Authors
Grace M. Niemiro
Adriana M. Coletta
Nadia H. Agha
Preteesh Leo Mylabathula
Forrest L. Baker
Abenaa M. Brewster
Therese B. Bevers
Enrique Fuentes-Mattei
Karen Basen-Engquist
Emmanuel Katsanis
Susan C. Gilchrist
Richard J. Simpson
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Immunity & Ageing / Issue 1/2022
Electronic ISSN: 1742-4933
DOI
https://doi.org/10.1186/s12979-022-00276-x

Other articles of this Issue 1/2022

Immunity & Ageing 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine